NervGen Pharma to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

          NervGen Pharma to Present at the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceJanuary 29, 2025 5:00 PM EST | Source: NervGen Pharma Corp.Vancouver, Canada--(Newsfile Corp. - January 29, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neurorestorative therapeutics, today announced that Mr. Mike Kelly, President & CEO, will be participating in a fireside chat at the Oppenheimer 35th Annual Healthcare Life Sciences C ...